Martin Shkreli, 10% Owner at KALOBIOS PHARMACEUTICALS INC (KBIO), sold 2,222,929 shares at $3.10 ($6.9M) on 2016-08-25, disclosed to the SEC on 2016-08-29.
Open-market sale of $6.9M KBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.10 | 1,913,206 | $5.9M | 86.1% |
| 2 | $3.10 | 309,723 | $960K | 13.9% |
| Total | $3.10 avg | 2,222,929 | $6.9M | 100% |
| Filing → |
| KBIO | BUY | 2015-11-19 | $889K | — | Filing → |
| KBIO | BUY | 2015-11-18 | $1.6M | — | Filing → |
| RTRX | SELL | 2014-11-24 | $10.4M | — | Filing → |